IPCA Labs - Strength in the Pharma sector
One of the few stocks which has had USFDA issues but eventually took it into its stride..
They focused more on the domestic market and now have a strong local franchise.
Long above 960 with a stoploss below 930.
The stock could breakout and move vertically.
They focused more on the domestic market and now have a strong local franchise.
Long above 960 with a stoploss below 930.
The stock could breakout and move vertically.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。